HOSPIRA INC, LAKE FOREST Recall: Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL
HOSPIRA INC, LAKE FOREST Recall: Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: HOSPIRA INC, LAKE FOREST; Product: Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parent
| Recalling firm | HOSPIRA INC, LAKE FOREST |
|---|---|
| Product | Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01 |
| Reason for recall | Presence of Particulate Matter: Silicone oil |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide in the USA |
| Recall initiated | 20170726 |
| Recall number | D-1080-2017 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →